Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS. Get full access to NPC Healthbiz Weekly at <a href="https://healthbiz.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4">healthbiz.substack.com/subscribe</a>

Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS. Get full access to NPC Healthbiz Weekly at <a href="https://healthbiz.substack.com/subscribe?utm_medium=podcast&amp;utm_campaign=CTA_4" rel="noopener noreferrer">healthbiz.substack.com/subscribe</a>

S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics

Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry. <a href="https://healthbiz.substack.com?utm_medium=podcast">healthbiz.substack.com</a>

Science

Life Sciences

Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry. healthbiz.substack.com

Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry. <a href="https://healthbiz.substack.com?utm_medium=podcast" rel="noopener noreferrer">healthbiz.substack.com</a>

Share S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics

Sign up to save your podcasts

S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics

S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics